NAPEPLD Antikörper
Kurzübersicht für NAPEPLD Antikörper (ABIN2726818)
Target
Alle NAPEPLD Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Homo sapiens N-acyl phosphatidylethanolamine phospholipase D (NAPEPLD), transcript variant 2
-
Aufreinigung
- Purified from mouse ascites fluids by affinity chromatography
-
Immunogen
- Full length human recombinant protein of human NAPEPLD(NP_075060) produced in HEK293T cell.
-
Isotyp
- IgG2b
-
-
-
-
Applikationshinweise
- WB 1:2000, IHC 1:150,
-
Kommentare
-
The concentration of the product may vary between diferrent lots.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5-1.0 mg/mL
-
Buffer
- PBS (PH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
-
- NAPEPLD (N-Acyl Phosphatidylethanolamine phospholipase D (NAPEPLD))
-
Andere Bezeichnung
- NAPEPLD
-
Hintergrund
- NAPEPLD is a phospholipase D type enzyme that catalyzes the release of N-acylethanolamine (NAE) from N-acyl-phosphatidylethanolamine (NAPE) in the second step of the biosynthesis of N-acylethanolamine (Okamoto et al., 2004 [PubMed 14634025]).
-
Molekulargewicht
- 45.4 kDa
-
Gen-ID
- 222236
-
NCBI Accession
- NM_198990
-
HGNC
- 222236
Target
-